Pfizer is penning a cancer discovery pact with Cartography Biosciences that could max out at $865 million biobucks. | Pfizer ...

By the beginning of 2025, it was clear the GLP-1 drugs were going to remain a major part of the industry. Pfizer used its presentation at the 43 rd JP Morgan Healthcre Conference to detail plans to ...

In the six weeks since the Food and Drug Administration authorized updated omicron boosters, it’s been unclear how much more protection the new version of the shot provides against infection. On ...

Collaboration leverages Cartography’s cutting-edge ATLAS and SUMMIT platforms to identify tumor-selective antigens; Pfizer to lead therapeutic development –– Cartography to receive upfront, near-term ...

New York, NY, and Saint-Herblain (France), December 4, 2023 – Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that they have completed recruitment for the ...

The MarketWatch News Department was not involved in the creation of this content. -- Strengthened Commercial Execution Driving Topline Growth -- Continued Progress Across R&D Pipeline -- Expanded ...

NEW YORK & BOSTON & WILMINGTON, Del.--(BUSINESS WIRE)-- Pfizer Inc. (NASDAQ:PFE), MorphoSys U.S. Inc., a fully owned subsidiary of MorphoSys AG (FSE: MOR; NASDAQ:MOR), and Incyte (NASDAQ:INCY) today ...

Pfizer's stock decline is linked to reduced 2026 revenue forecasts due to lower Covid vaccine sales and patent expirations. The company prioritizes development investments over share repurchases, ...

As the spring saw another surge of coronavirus cases across the country, healthcare officials are urging people to get vaccinated. But some social media posts are spreading false claims that the ...

In the latest close session, Pfizer (PFE) was up +1.12% at $25.18. The stock outpaced the S&P 500's daily gain of 0.19%. Meanwhile, the Dow experienced a rise of 0.66%, and the technology-dominated ...